Kidney News and Research

RSS

Genetic factors influence cholesterol response to low-carb diets

Can a low-carb diet cause your cholesterol to skyrocket? This question has vexed researchers and influencers alike as the popularity of low-carbohydrate diets has surged, yet the evidence has remained mixed.

27 Jul 2026

Signals traveling from the gut through the vagus nerve help form memories

When French writer Marcel Proust famously recalled his childhood from the taste of a Madeline cookie, his stomach may have done some of the work.

27 Jul 2026

Primary care practices successfully deliver family-based childhood obesity treatment

Childhood obesity affects one in five children in the U.S., yet most families have limited access to specialized weight-management programs for children.

27 Jul 2026

Beckman Coulter Diagnostics launches fully automated urinalysis system to meet rising testing volumes

Beckman Coulter Diagnostics, a Danaher company and a global leader in clinical diagnostics, today announced the U.S. launch of the DxU 1800 System, a fully automated urinalysis solution that combines a new chemistry analyzer and consumables with proven microscopy technology.

From Beckman Coulter Diagnostics 27 Jul 2026

Photo-based calorie-tracking apps fall short in estimating meal nutrition

Thanks to advances in AI, popular calorie-tracking apps can now use a photo of a meal to estimate the nutritional content of what you're eating.

26 Jul 2026

Study links household drinking water to long-term lithium exposure

Lithium in drinking water is a widespread and persistent source of human exposure across Tribal communities in the Western United States, according to a new study from Columbia University Mailman School of Public Health.

24 Jul 2026

Iowa State study identifies potential new target for leukemia treatment

In leukemia's most aggressive forms, the blood cell factories in our bone marrow falter. Instead of dividing and multiplying at their usual prolific pace, generating hundreds of billions of new cells daily, some precursor cells stall out at an immature stage.

24 Jul 2026

Taiwan Biobank data reveals ongoing natural selection in living humans

For more than a century, scientists have sought to reconstruct human evolution using diverse lines of evidence, including fossils, genetic variation across populations, and ancient DNA.

24 Jul 2026

Cleveland Clinic study links gut microbe byproduct to heart arrhythmia

A Cleveland Clinic-led study shows a connection between elevated blood levels of TMAO (trimethylamine N-oxide) - a byproduct of gut bacteria digestion of nutrients found in red meat and other animal products - and a higher risk of atrial fibrillation.

24 Jul 2026

Lifestyle changes improve MASLD by suppressing key molecular pathway

Lifestyle modification is the cornerstone of managing metabolic dysfunction-associated steatotic liver disease (MASLD), a growing cause of chronic liver disease worldwide.

23 Jul 2026

New bacterial control strategy helps revive failing last-line antibiotics

Antimicrobial resistance is one of the world's most alarming public health challenges, because the multidrug-resistant (MDR) gram-negative bacteria increasingly render even last-line antibiotics ineffective, leading to substantially higher mortality rates.

23 Jul 2026

GLP-1 receptor agonists may increase hair loss risk

Use of glucagon-like peptide-1 (GLP-1) receptor agonists used to treat type 2 diabetes and obesity are associated with an increased risk of hair loss (alopecia) in adults with type 2 diabetes, finds a study published by The BMJ today.

22 Jul 2026

Generic semaglutide could improve diabetes treatment affordability in Canada

In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers predict that the anticipated price reductions of up to 70% will dramatically increase both the cost-effectiveness and health system affordability of therapy options for patients with type 2 diabetes and high cardiorenal risk.

22 Jul 2026

Study reveals sex-based protein differences across lung cancer types

Biological sex factors into cancer in ways you might not expect. In lung cancer, a form called squamous cell carcinoma disproportionately affects males while adenocarcinoma occurs more frequently in females.

21 Jul 2026

Common heart risk calculators effectively predict certain types of cancer

Risk calculators that doctors use to estimate a person's risk of a heart attack or stroke work about as well for predicting certain cancers, according to a new study by UCL (University College London) researchers.

21 Jul 2026

Experts urge focus on prevention to tackle global heart failure

Heart failure already affects more than 60 million people worldwide and is one of the leading causes of hospitalization among people over the age of 65.

21 Jul 2026

Thymus hormone identified as key player in reversing age-related inflammation

Chronic, low-grade inflammation in the body-a phenomenon known as "inflammaging" because it increases with age-has been linked to many of today's leading causes of illness and death, including cancer, heart disease, metabolic conditions and neurodegenerative diseases.

21 Jul 2026

Study examines the link between blood type and cardiovascular risk in hemodialysis patients

Do you know your blood type? It is important information that is used for blood transfusions, but few realize blood types could also be linked to disease risks. In the general population, people with blood type O have been reported to have a lower risk of cardiovascular disease and cardiovascular mortality.

21 Jul 2026

Study tests chronotype’s liver link and finds no significant association

Researchers found no significant association between chronotype and FibroScan-derived liver fat or stiffness in 119 medication-naïve adults with overweight or obesity. The exploratory findings cannot exclude smaller effects, particularly for fibrosis, and require confirmation in larger longitudinal studies.

21 Jul 2026

High costs continue limiting insurance coverage for GLP-1 medications

Despite growing evidence that GLP-1 medications improve health and are worth their cost, many insurance plans still limit coverage. University of Mississippi researchers are examining why, and where that leaves patients.

20 Jul 2026